Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 5
2010 4
2011 3
2012 3
2013 6
2014 5
2015 6
2016 3
2017 9
2018 7
2019 9
2020 10
2021 8
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Gene Expression Assay in the Management of Early Breast Cancer.
Caputo R, Cianniello D, Giordano A, Piezzo M, Riemma M, Trovò M, Berretta M, De Laurentiis M. Caputo R, et al. Among authors: trovo m. Curr Med Chem. 2020;27(17):2826-2839. doi: 10.2174/0929867326666191205163329. Curr Med Chem. 2020. PMID: 31804159 Review.
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients.
Francolini G, Porreca A, Facchini G, Santini D, Bruni A, Simoni N, Trovò M, Osti MF, Fornarini G, Sisani M, Di Cataldo V, Detti B, Garlatti P, Bertini N, Serni S, Minervini A, Livi L. Francolini G, et al. Among authors: trovo m. Med Oncol. 2023 Dec 29;41(1):39. doi: 10.1007/s12032-023-02268-3. Med Oncol. 2023. PMID: 38157111 Clinical Trial.
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy.
Arcangeli S, Jereczek-Fossa BA, Alongi F, Aristei C, Becherini C, Belgioia L, Buglione M, Caravatta L, D'Angelillo RM, Filippi AR, Fiore M, Genovesi D, Greco C, Livi L, Magrini SM, Marvaso G, Mazzola R, Meattini I, Merlotti A, Palumbo I, Pergolizzi S, Ramella S, Ricardi U, Russi E, Trovò M, Sindoni A, Valentini V, Corvò R. Arcangeli S, et al. Among authors: trovo m. Crit Rev Oncol Hematol. 2019 Feb;134:87-103. doi: 10.1016/j.critrevonc.2018.11.005. Epub 2018 Dec 1. Crit Rev Oncol Hematol. 2019. PMID: 30658886 Review.
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy.
Cortiula F, Hendriks LEL, Wijsman R, Houben R, Steens M, Debakker S, Canters R, Trovò M, Sijtsema NM, Niezink AGH, Unipan M, Urban S, Michelotti A, Dursun S, Bootsma G, Hattu D, Nuyttens JJ, Moretti E, Taasti VT, De Ruysscher D. Cortiula F, et al. Among authors: trovo m. Radiother Oncol. 2024 Jan;190:110019. doi: 10.1016/j.radonc.2023.110019. Epub 2023 Nov 22. Radiother Oncol. 2024. PMID: 38000689 Free article.
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity.
Arcangeli S, Jereczek-Fossa BA, Alongi F, Aristei C, Becherini C, Belgioia L, Buglione M, Caravatta L, D'Angelillo RM, Filippi AR, Fiore M, Genovesi D, Greco C, Livi L, Magrini SM, Marvaso G, Mazzola R, Meattini I, Merlotti A, Palumbo I, Pergolizzi S, Ramella S, Ricardi U, Russi E, Trovò M, Sindoni A, Valentini V, Corvò R. Arcangeli S, et al. Among authors: trovo m. Crit Rev Oncol Hematol. 2019 Feb;134:104-119. doi: 10.1016/j.critrevonc.2018.11.006. Epub 2018 Nov 30. Crit Rev Oncol Hematol. 2019. PMID: 30658887 Review.
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?
Alongi F, Arcangeli S, Ramella S, Giaj-Levra N, Borghetti P, D'angelillo R, Ricchetti F, Maddalo M, Mazzola R, Trovò M, Russi E, Magrini SM; on the behalf of Associazione Italiana Radioterapia Oncologica (AIRO). Alongi F, et al. Among authors: trovo m. Expert Rev Anticancer Ther. 2017 Feb;17(2):157-165. doi: 10.1080/14737140.2017.1273111. Epub 2017 Jan 5. Expert Rev Anticancer Ther. 2017. PMID: 27984919 Review.
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Merlotti A, Bruni A, Borghetti P, Ramella S, Scotti V, Trovò M, Chiari R, Lohr F, Ricardi U, Bria E, Pappagallo GL, D'Angelillo RM, Arcangeli S. Merlotti A, et al. Among authors: trovo m. Radiol Med. 2021 Aug;126(8):1117-1128. doi: 10.1007/s11547-021-01362-8. Epub 2021 May 5. Radiol Med. 2021. PMID: 33954898 Review.
69 results